Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 4.11 is 61% above its 5-year average of 2.55, near the high end of its 5-year range (-0.67–4.91).
As of the fiscal period ended Wednesday, December 31, 2025. 2.62% above its 12-month average of 4.00.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
4.11
EARNINGS PER SHARE (EPS) AVG TTM
4.00
EARNINGS PER SHARE (EPS) AVG 3Y
3.51
EARNINGS PER SHARE (EPS) AVG 5Y
2.55
EARNINGS PER SHARE (EPS) AVG 10Y
2.71
EARNINGS PER SHARE (EPS) AVG 15Y
2.72
EARNINGS PER SHARE (EPS) AVG 20Y
3.13
CURRENT VS TTM AVG
+2.62%
CURRENT VS 3Y AVG
+17.26%
CURRENT VS 5Y AVG
+61.39%
CURRENT VS 10Y AVG
+51.56%
CURRENT VS 15Y AVG
+50.99%
CURRENT VS 20Y AVG
+31.40%
Zimmer Biomet Holdings, Inc.
Market Cap
$18.99B
Earnings Per Share (EPS)
4.11
TTM Avg
4.00
3Y Avg
3.51
5Y Avg
2.55
Market Cap
$20.55B
Earnings Per Share (EPS)
-0.26
TTM Avg
-1.77
3Y Avg
-0.44
5Y Avg
-0.66
Market Cap
$16.41B
Earnings Per Share (EPS)
17.07
TTM Avg
14.35
3Y Avg
11.37
5Y Avg
9.10
Market Cap
$22.03B
Earnings Per Share (EPS)
27.91
TTM Avg
28.29
3Y Avg
23.40
5Y Avg
19.31
Market Cap
$22.32B
Earnings Per Share (EPS)
-7.98
TTM Avg
-8.27
3Y Avg
-1.90
5Y Avg
3.46
Market Cap
$15.15B
Earnings Per Share (EPS)
8.19
TTM Avg
5.85
3Y Avg
6.82
5Y Avg
7.06
Market Cap
$23.16B
Earnings Per Share (EPS)
-5.94
TTM Avg
-4.08
3Y Avg
9.21
5Y Avg
14.48
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $18.99B | 4.11 | 4.00 | 3.51 | 2.55 |
| Viatris Inc. (VTRS)vs › | $20.55B | -0.26 | -1.77 | -0.44 | -0.66 |
| Hologic, Inc. (HOLX)vs › | $16.97B | 2.40 | 2.92 | 3.22 | 4.07 |
| Medpace Holdings, Inc. (MEDP)vs › | $16.41B | 17.07 | 14.35 | 11.37 | 9.10 |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 27.91 | 28.29 | 23.40 | 19.31 |
| Moderna, Inc. (MRNA)vs › | $22.32B | -7.98 | -8.27 | -1.90 | 3.46 |
| STERIS plc (STE)vs › | $22.68B | 8.18 | 7.08 | 4.77 | 4.37 |
| Solventum Corporation (SOLV)vs › | $15.15B | 8.19 | 5.85 | 6.82 | 7.06 |
| BioNTech SE (BNTX)vs › | $23.16B | -5.94 | -4.08 | 9.21 | 14.48 |
| The Cooper Companies, Inc. (COO)vs › | $14.60B | 1.18 | 1.92 | 1.82 | 11.98 |
Trailing EPS (TTM)
$4.11
Forward EPS (Est.)
$8.49
P/E Ratio
23.9
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 3.56 |
| 2024-12-31 | 4.45 |
| 2023-12-31 | 4.91 |
| 2022-12-31 | 1.10 |
| 2021-12-31 | 1.93 |
| 2020-12-31 | -0.67 |
| 2019-12-31 | 5.52 |
| 2018-12-31 | -1.86 |
| 2017-12-31 | 9.11 |
| 2016-12-31 | 1.51 |
| 2015-12-31 | 0.27 |
| 2014-12-31 | 4.26 |
| 2013-12-31 | 4.49 |
| 2012-12-31 | 4.32 |
| 2011-12-31 | 4.06 |
| 2010-12-31 | 2.98 |
| 2009-12-31 | 3.34 |
| 2008-12-31 | 3.73 |
| 2007-12-31 | 3.28 |
| 2006-12-31 | 3.43 |
| 2005-12-31 | 2.96 |
| 2004-12-31 | 2.22 |
| 2003-12-31 | 1.67 |
| 2002-12-31 | 1.33 |
| 2001-12-31 | 0.77 |
| 2000-12-31 | 0.91 |
| 1999-12-31 | 0.77 |
| 1998-12-31 | 0.75 |
Reported annual fiscal-period values; no daily interpolation.
